CTKB — Cytek Biosciences Share News
0.000.00%
Last trade - 00:00- $703.21m
- $450.88m
- $201.49m
Brief: Cytek Biosciences Reports First Quarter 2022 Financial Results
Cytek Biosciences Inc expected to post breakeven results a share - Earnings Preview
Brief: Cytek Biosciences Reports Q4 And Full Year 2021 Results
Brief: Cytek Biosciences Inc - Increased Number Of Authorized Directors On Board From Six To Seven
U.S. RESEARCH ROUNDUP-Akamai Technologies, Gitlab, RPM International
Brief: Cytek Biosciences Reports Q3 2021 Financial Results
Brief: Cytek Biosciences Acquires Tonbo Biosciences’ Cell Analysis Business
Brief: Cytek Bio Says Co, Unit Entered Into A Supply Agreement With Coherent
Brief: Cytek Biosciences Says RA Capital Management Reports 7.2% Stake In Co As Of July 27
Brief: Cytek Biosciences Shares Open 18.2% Above IPO Price In Nasdaq Debut
NASDAQ RESUMED AT 12:02 PM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 04:00 AM
Brief: Cytek Biosciences Announces Pricing Of Its Initial Public Offering